Fifth disease - Mate Tuarima
☆ I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
16-marama te pakeke me te Mate Tuarima (Fifth disease) ― Ka whero nga paparinga e rua, me te mea e pakipakihia ana, ka puta mai nga maculopapular rashes ki runga i te tinana.
Erythema ki nga paparinga e rua.
References
Ko te Fifth disease , e mohiotia ana ko te erythema infectiosum, he mate huaketo na te parvovirus B19 tangata. Ka kaha ake i roto i nga tamariki, ka pa ki te hunga kei waenga i te 4 ki te 14 tau. I te nuinga o te wa ka timata nga tohu ki te kirika ngawari, ki te mahunga, ki te korokoro, me te ahua o te rewharewha. Ka taea e nga tamariki te ahua o te kiri whero i runga i te mata he rite ki te slapped cheeks , me te ahua o te ponana ki te tinana, ringa me nga waewae. I roto i nga pakeke, ko te mamae tahi he amuamu noa, tera pea ka puta i nga wiki i muri i te mate tuatahi. Ko te mea nui, tata ki te 20 ki te 30% o nga pakeke kua pangia e te parvovirus B19 kare pea he tohu tohu.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Kei te 33% te morearea o te tuku parvovirus B19 mai i te whaea ki te peepi, me te 3% o nga wahine kua pangia e pa ana ki nga raruraru i roto i a ratou kohungahunga. Ka pangia te whaea i mua i te 20 wiki o te haputanga, ka piki ake te tupono o nga raruraru penei i te raruraru toto me te hanga wai i roto i te tinana o te peepi. Hei timata ki te whakahaere i tenei mate, me tirotiro mena kua pa te mate ki te parvovirus ma te whakamatautau mo etahi antibodies (IgM) . Mena karekau he rongo o mua i te whakamatautau engari ka tohu he mate no tata nei, me aro turuki te manawanui i te wa e hapu ana, tae atu ki te tirotiro i te ultrasound ki te tirotiro mo etahi take hauora o te peepi.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
mate tuarima (fifth disease) ka timata ki te kirika iti, kirikaa, kirika, me nga tohu ahua makariri, penei i te ihu pupuhi, te ihu pupuhi ranei. Ka pahemo enei tohu, katahi i etahi ra i muri mai, ka puta te pupuhi. Ka kitea te kiri whero kanapa ki te mata, ina koa nga paparinga. (no reira te ingoa "mate paparinga paparinga"). I tua atu i nga paparinga whero, he maha nga wa ka puta nga tamariki i te whero, i te rekereke i runga i te toenga o te tinana, ko nga ringaringa o runga, te rama, me nga waewae te waahi nui.
He ngawari te mate, engari ki nga wahine hapu, ko te mate i te marama tuatahi kua honoa ki te hydrops fetalis, ka mate ohorere.
○ Maimoatanga
Kaore e hiahiatia he maimoatanga motuhake na te mea ka pai ake te waa.